rs11466334
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000660.7(TGFB1):c.860+51C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00447 in 1,610,914 control chromosomes in the GnomAD database, including 276 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.023 ( 133 hom., cov: 31)
Exomes 𝑓: 0.0025 ( 143 hom. )
Consequence
TGFB1
NM_000660.7 intron
NM_000660.7 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.52
Publications
11 publications found
Genes affected
TGFB1 (HGNC:11766): (transforming growth factor beta 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]
TGFB1 Gene-Disease associations (from GenCC):
- Camurati-Engelmann diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- inflammatory bowel disease, immunodeficiency, and encephalopathyInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- cystic fibrosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 19-41341832-G-A is Benign according to our data. Variant chr19-41341832-G-A is described in ClinVar as Benign. ClinVar VariationId is 1261994.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0764 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TGFB1 | ENST00000221930.6 | c.860+51C>T | intron_variant | Intron 5 of 6 | 1 | NM_000660.7 | ENSP00000221930.4 |
Frequencies
GnomAD3 genomes AF: 0.0229 AC: 3483AN: 152184Hom.: 131 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
3483
AN:
152184
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00590 AC: 1469AN: 249192 AF XY: 0.00441 show subpopulations
GnomAD2 exomes
AF:
AC:
1469
AN:
249192
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00254 AC: 3710AN: 1458612Hom.: 143 Cov.: 32 AF XY: 0.00223 AC XY: 1615AN XY: 725700 show subpopulations
GnomAD4 exome
AF:
AC:
3710
AN:
1458612
Hom.:
Cov.:
32
AF XY:
AC XY:
1615
AN XY:
725700
show subpopulations
African (AFR)
AF:
AC:
2790
AN:
33400
American (AMR)
AF:
AC:
202
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
AC:
44
AN:
26122
East Asian (EAS)
AF:
AC:
1
AN:
39684
South Asian (SAS)
AF:
AC:
18
AN:
86092
European-Finnish (FIN)
AF:
AC:
0
AN:
53252
Middle Eastern (MID)
AF:
AC:
27
AN:
4222
European-Non Finnish (NFE)
AF:
AC:
328
AN:
1110964
Other (OTH)
AF:
AC:
300
AN:
60172
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
199
399
598
798
997
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0229 AC: 3495AN: 152302Hom.: 133 Cov.: 31 AF XY: 0.0213 AC XY: 1588AN XY: 74470 show subpopulations
GnomAD4 genome
AF:
AC:
3495
AN:
152302
Hom.:
Cov.:
31
AF XY:
AC XY:
1588
AN XY:
74470
show subpopulations
African (AFR)
AF:
AC:
3267
AN:
41556
American (AMR)
AF:
AC:
147
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
9
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5188
South Asian (SAS)
AF:
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
29
AN:
68028
Other (OTH)
AF:
AC:
41
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
164
328
491
655
819
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
21
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.